Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

NCT05974059 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Unresectable Gastric Adenocarcinoma

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Cadonilimab

Sponsor

Tianjin Medical University Cancer Institute and Hospital